Class III · Lower riskActive recall
FentaNYL Citrate PF
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025.
Where it was soldNationwide in the U.S.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Labeling: Incorrect or Missing Lot and/or Exp Date
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | STAQ Pharma, Inc. |
| NDC | 73177-0102-05 |
Show the full FDA record
| Full product label | FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05. |
| Recalling firm | STAQ Pharma, Inc. |
| Distribution | Nationwide in the U.S. |
| Recall initiated | 2025-10-09 |
| Report date | 2025-10-22 |
| Recall completed | — |
| Recall number | D-0025-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Denver CO United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.